Mikkel Østergaard Selected Research

Tenosynovitis

2/2024	Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
10/2017	Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
1/2017	Intramuscular versus ultrasound-guided intratenosynovial glucocorticoid injection for tenosynovitis in patients with rheumatoid arthritis: a randomised, double-blind, controlled study.
5/2015	Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?
5/2015	A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikkel Østergaard Research Topics

Disease

81	Rheumatoid Arthritis 03/2024 - 06/2003
40	Inflammation (Inflammations) 02/2024 - 01/2009
36	Axial Spondyloarthritis 04/2024 - 08/2011
27	Ankylosing Spondylitis 04/2024 - 04/2007
27	Synovitis 02/2024 - 06/2003
16	Psoriatic Arthritis 04/2024 - 02/2011
15	Pain (Aches) 01/2024 - 01/2009
8	Fatigue 01/2024 - 01/2015
7	Osteitis 02/2024 - 11/2011
7	Arthritis (Polyarthritis) 02/2023 - 08/2011
7	Edema (Dropsy) 01/2022 - 06/2003
6	Necrosis 05/2023 - 08/2011
6	Rheumatic Diseases (Rheumatism) 02/2023 - 01/2010
5	Tenosynovitis 02/2024 - 05/2015
5	Non-Radiographic Axial Spondyloarthritis 01/2023 - 01/2017
5	Infections 01/2020 - 03/2016
4	Gout 11/2022 - 09/2018
4	Sacroiliitis 09/2022 - 01/2020
4	Back Pain (Backache) 01/2022 - 10/2010
3	Neoplasms (Cancer) 01/2024 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 01/2023
2	Knee Osteoarthritis 01/2023 - 05/2014
2	Ankylosis 01/2022 - 03/2020
2	Joint Diseases (Joint Disease) 01/2020 - 02/2014
2	Body Weight (Weight, Body) 09/2017 - 05/2006
1	Arthralgia (Joint Pain) 02/2024
1	Low Back Pain (Lumbago) 09/2023
1	Spondylitis 08/2023

Drug/Important Bio-Agent (IBA)

25	Tumor Necrosis Factor InhibitorsIBA 05/2024 - 12/2014
22	C-Reactive ProteinIBA 04/2024 - 04/2004
21	Adalimumab (Humira)FDA Link 03/2024 - 08/2006
18	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 05/2006
17	Antirheumatic Agents (DMARD)IBA 03/2024 - 08/2009
16	Biomarkers (Surrogate Marker)IBA 09/2023 - 08/2011
12	Abatacept (Orencia)FDA Link 02/2024 - 01/2016
10	ametantrone (HAQ)IBA 01/2024 - 10/2009
9	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 04/2009
8	Rheumatoid FactorIBA 12/2020 - 01/2011
7	secukinumabIBA 03/2024 - 01/2020
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 09/2007
7	Monoclonal AntibodiesIBA 03/2020 - 08/2010
5	golimumab FDA Link 11/2020 - 11/2011
4	tocilizumab (atlizumab)FDA Link 10/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2009
4	cyclic citrullinated peptideIBA 09/2023 - 04/2009
4	Matrix Metalloproteinases (MMPs)IBA 12/2022 - 08/2011
4	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/2022 - 04/2016
4	Infliximab (Remicade)FDA Link 12/2022 - 09/2007
4	Uric Acid (Urate)IBA 11/2022 - 09/2018
4	ixekizumabIBA 11/2022 - 01/2020
4	Interleukin-17 (Interleukin 17)IBA 09/2022 - 01/2020
4	AutoantibodiesIBA 01/2021 - 10/2014
4	Betamethasone (Celestone)FDA Link 01/2017 - 05/2006
3	Biosimilar PharmaceuticalsIBA 03/2024 - 12/2019
3	Certolizumab Pegol FDA Link 10/2023 - 12/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2011
3	Etanercept (Enbrel)FDA Link 12/2022 - 01/2010
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2016
3	ofatumumab FDA Link 01/2016 - 08/2010
3	Immunoglobulin M (IgM)IBA 08/2014 - 08/2011
3	Cartilage Oligomeric Matrix ProteinIBA 12/2011 - 08/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 11/2020
2	FicolinsIBA 09/2023 - 12/2013
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 09/2023 - 04/2009
2	tofacitinibIBA 08/2023 - 06/2016
2	CollagenIBA 12/2022 - 01/2022
2	catch-relaxing peptide (Mytilus)IBA 12/2022 - 01/2022
2	Complement C4 (Complement Component 4)IBA 12/2022 - 01/2022
2	InterleukinsIBA 09/2022 - 03/2020
2	GLPG0634IBA 01/2022 - 01/2022
2	LipidsIBA 03/2021 - 09/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 04/2016
2	GlucocorticoidsIBA 01/2017 - 01/2017
2	ORALIT (ORS)IBA 04/2016 - 01/2010
2	Triamcinolone (Aristocort)FDA Link 05/2015 - 04/2014
2	GadoliniumIBA 05/2015 - 06/2003
2	Collagen Type II (Type II Collagen)IBA 12/2011 - 08/2011
2	OsteocalcinIBA 12/2011 - 08/2011
2	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 12/2011 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 08/2011
2	Aggrecans (Aggrecan)IBA 12/2011 - 08/2011
2	Fenofibrate (CiL)FDA LinkGeneric 07/2011 - 01/2009
2	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 12/2010 - 10/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2010 - 05/2006
1	ProstaglandinsIBA 03/2024
1	acetyl 4-aminosalicylic acidIBA 02/2024
1	Prostaglandins AIBA 01/2024
1	Complement System Proteins (Complement)IBA 09/2023
1	Edetic Acid (EDTA)FDA Link 09/2023
1	Serine Proteases (Serine Protease)IBA 09/2023
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 09/2023
1	Collectins (Collectin)IBA 09/2023
1	LectinsIBA 09/2023

Therapy/Procedure

35	Therapeutics 10/2023 - 05/2006
4	Aftercare (After-Treatment) 11/2021 - 04/2007
3	Drug Tapering 01/2021 - 01/2016
3	Biological Therapy 01/2019 - 09/2013
2	Activities of Daily Living (ADL) 03/2024 - 03/2020
2	Injections 05/2015 - 06/2012
2	Intra-Articular Injections 06/2012 - 10/2010